BAX

Analyzing Baxter International – A Stock Overview

Shares of Baxter International have moved 1.3% today, and are now trading at a price of $29.0. In contrast, the S&P 500 index saw a 0.0% change. Today's trading volume is 304,076 compared to the stock's average volume of 4,210,939.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. Based in Deerfield, United States the company has 60,000 full time employees and a market cap of $14,804,499,456. Baxter International currently offers its equity investors a dividend that yields 4.1% per year.

The company is now trading -28.74% away from its average analyst target price of $40.69 per share. The 14 analysts following the stock have set target prices ranging from $30.0 to $62.0, and on average give Baxter International a rating of hold.

Over the last 12 months BAX shares have declined by -26.3%, which represents a difference of -50.9% when compared to the S&P 500. The stock's 52 week high is $44.01 per share and its 52 week low is $28.34. Based on Baxter International's average net margin growth of 4.2% over the last 6 years, its core business remains strong and the stock price may recover in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023 14,813,000 2,656,000 18 205.88
2022 14,506,000 -2,433,000 -17 -254.55
2021 12,146,000 1,284,000 11 22.22
2020 11,673,000 1,102,000 9 0.0
2019 11,362,000 1,001,000 9 -35.71
2018 11,099,000 1,546,000 14
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS